- Investigator
- James Wymer
- Status
- Accepting Candidates
Research at a glance
Top areas of exploration
- Amyotrophic Lateral Sclerosis , 32 publications
- Deglutition Disorders , 12 publications
- Deglutition , 11 publications
- Cough , 6 publications
Research activity
Active clinical trials
The purpose of this study is to evaluate the efficacy, safety, tolerability and pharmacokinetics of NMD670 in the treatment of ambulatory adults with spinal muscular atrophy type 3
- Investigator
- James Wymer
- Status
- Accepting Candidates
- Ages
- 18 Years - 75 Years
- Sexes
- All
The HEALEY ALS Platform Trial is a perpetual multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of ALS.
- Investigator
- James Wymer
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
My publications
Filter publications
50 publications
2025
Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
JAMA network open
PubMed • Publisher's site2024
Diagnoses of muscular dystrophy in a veterans health system.
Muscle & nerve
PubMed • Publisher's site2024
Leveraging deep single-soma RNA sequencing to explore the neural basis of human somatosensation.
Nature neuroscience
PubMed • Publisher's site2024
Relationship between pulmonary, cough, and swallowing functions in individuals with amyotrophic lateral sclerosis.
Muscle & nerve
PubMed • Publisher's site2023
Dextromethorphan/quinidine for the treatment of bulbar impairment in amyotrophic lateral sclerosis.
Annals of clinical and translational neurology
PubMed • Publisher's site